[{"address1": "11400 West Olympic Boulevard", "address2": "Suite 200", "city": "Los Angeles", "state": "CA", "zip": "90064", "country": "United States", "phone": "310 651 8041", "website": "https://www.immixbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The company' lead product is NXC-201 for relapsed/refractory AL Amyloidos. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.", "fullTimeEmployees": 18, "companyOfficers": [{"maxAge": 1, "name": "Dr. Ilya  Rachman M.B.A., M.D., MBA, Ph.D.", "age": 51, "title": "Co-Founder, CEO & Chairman", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 712500, "exercisedValue": 0, "unexercisedValue": 120332}, {"maxAge": 1, "name": "Mr. Gabriel  Morris B.A.", "age": 37, "title": "CFO & Director", "yearBorn": 1987, "fiscalYear": 2024, "totalPay": 712500, "exercisedValue": 0, "unexercisedValue": 461582}, {"maxAge": 1, "name": "Dr. Graham  Ross FFPM, M.D.", "age": 64, "title": "Chief Medical Officer & Head of Clinical Development", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 88593, "exercisedValue": 0, "unexercisedValue": 5100}, {"maxAge": 1, "name": "Mr. Sean  Senn J.D., M.B.A., M.Sc., MBA, MSc", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Vladimir P. Torchilin D.Sc., MSE, Ph.D.", "age": 77, "title": "Scientific Co-Founder", "yearBorn": 1947, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Marks MBBS, Ph.D.", "title": "Chief Medical Officer of Cell Therapy", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gerhard  Bauer", "title": "Head of Cell Therapy Manufacturing", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.41, "open": 2.1, "dayLow": 1.9, "dayHigh": 2.14, "regularMarketPreviousClose": 2.41, "regularMarketOpen": 2.1, "regularMarketDayLow": 1.9, "regularMarketDayHigh": 2.14, "payoutRatio": 0.0, "beta": 0.262, "forwardPE": -3.6181817, "volume": 1122307, "regularMarketVolume": 1122307, "averageVolume": 134744, "averageVolume10days": 559930, "averageDailyVolume10Day": 559930, "bid": 1.95, "ask": 2.01, "bidSize": 2, "askSize": 2, "marketCap": 55475828, "fiftyTwoWeekLow": 1.26, "fiftyTwoWeekHigh": 2.71, "fiftyDayAverage": 1.83876, "twoHundredDayAverage": 1.869585, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 42856736, "profitMargins": 0.0, "floatShares": 17986658, "sharesOutstanding": 27877300, "sharesShort": 191305, "sharesShortPriorMonth": 367356, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0069, "heldPercentInsiders": 0.40921003, "heldPercentInstitutions": 0.12092, "shortRatio": 3.9, "shortPercentOfFloat": 0.0216, "impliedSharesOutstanding": 27877300, "bookValue": 0.481, "priceToBook": 4.137214, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -21613376, "trailingEps": -0.69, "forwardEps": -0.55, "enterpriseToEbitda": -1.893, "52WeekChange": -0.13852817, "SandP52WeekChange": 0.09362543, "quoteType": "EQUITY", "currentPrice": 1.99, "targetHighPrice": 7.0, "targetLowPrice": 7.0, "targetMeanPrice": 7.0, "targetMedianPrice": 7.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 17681954, "totalCashPerShare": 0.638, "ebitda": -22641740, "totalDebt": 1074770, "quickRatio": 2.263, "currentRatio": 2.325, "debtToEquity": 8.111, "returnOnAssets": -0.66110003, "returnOnEquity": -1.47334, "freeCashflow": -7551199, "operatingCashflow": -14595102, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "IMMX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1639665000000, "shortName": "Immix Biopharma, Inc.", "longName": "Immix Biopharma, Inc.", "corporateActions": [], "postMarketTime": 1748044670, "regularMarketTime": 1748030400, "regularMarketChangePercent": -17.427387, "regularMarketPrice": 1.99, "postMarketChangePercent": -1.00502, "postMarketPrice": 1.97, "postMarketChange": -0.02, "regularMarketChange": -0.42000008, "regularMarketDayRange": "1.9 - 2.14", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 134744, "fiftyTwoWeekLowChange": 0.73, "fiftyTwoWeekLowChangePercent": 0.5793651, "fiftyTwoWeekRange": "1.26 - 2.71", "fiftyTwoWeekHighChange": -0.72, "fiftyTwoWeekHighChangePercent": -0.26568267, "fiftyTwoWeekChangePercent": -13.852817, "earningsTimestamp": 1746734400, "earningsTimestampStart": 1754942400, "earningsTimestampEnd": 1755288000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.69, "epsForward": -0.55, "epsCurrentYear": -0.57, "priceEpsCurrentYear": -3.491228, "fiftyDayAverageChange": 0.15123999, "fiftyDayAverageChangePercent": 0.08225108, "twoHundredDayAverageChange": 0.12041497, "twoHundredDayAverageChangePercent": 0.06440733, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-12-16", "averageAnalystRating": "2.0 - Buy", "exchange": "NCM", "messageBoardId": "finmb_417356223", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "displayName": "Immix Biopharma", "trailingPegRatio": null, "__fetch_time": "2025-05-24"}]